Relationship of immunohistochemical biomarker expression and lymph node involvement in patients undergoing surgical treatment of NSCLC with long-term follow-up
- 86 Downloads
We try to identify the relationship between immunohistochemical marker expression and lymph node involvement in a cohort of 282 patients followed for 5 years after curative resection for NSCLC. In 189 patients (67 %), lymph nodes were unaffected while 93 patients (33 %) showed nodal involvement. The expression of 15 molecular markers was determined from each patient by tissue-array immunohistochemistry. Univariate analysis indicated significantly higher expression of E-cadherin, γ-catenin, p27, and p53 in patients with lymph node involvement. In those with unaffected nodes, p16 and Rb were expressed. E-cadherin expression was related to a 50 % mortality reduction in patients with node involvement (hazard ratio (HR) 0.5; p = 0.017). c-erbB-2 expression was correlated with a 3.4-fold increase in mortality compared to patients without expression of this marker in subjects without node involvement (HR 3.41; p = 0.017). Multivariate analysis identified c-erbB-2 (HR 2.22; p = 0.089) and p27 (HR 1.44; p = 0.019) as prognostics of mortality while Rb (HR 0.74) indicated a good prognosis. The expression of proteins encoded by oncogenes and tumor suppressor genes was different according to lymph node involvement. The increased mortality related to c-erbB-2 expression in patients with unaffected lymph nodes would suggests a need for adjuvant treatment.
KeywordsNon-small cell lung cancer Gene expression Lymph nodes Tissue array Prognosis c-erb-2
Fundación Mutua Madrileña.
Conflicts of interest
- 20.Sanchez PA, Torres AJ, Iniesta P, et al. Prognostic significance of p53 gene mutations in squamous cell carcinoma of the lung. Oncol R. 1998;5:1129–33.Google Scholar
- 23.Baldi A, De Luca A, Esposito V. et al. Tumor suppressors and cell-cycle proteins in lung cancer. Review article. Pathology Research International 2011;1-12Google Scholar
- 46.Donnem T, Lonvik K, Eklo K, et al. Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival.n2011;117:3193-3200Google Scholar